Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 3
1983 4
1984 6
1985 5
1986 7
1987 6
1988 8
1989 5
1990 10
1991 7
1992 7
1993 9
1994 13
1995 12
1996 9
1997 13
1998 15
1999 19
2000 15
2001 12
2002 17
2003 10
2004 13
2005 9
2006 15
2007 10
2008 15
2009 16
2010 15
2011 15
2012 14
2013 21
2014 20
2015 21
2016 21
2017 21
2018 14
2019 10
2020 16
2021 20
2022 11
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

485 results

Results by year

Filters applied: . Clear all
Page 1
Rebuttal From Dr O'Byrne.
O'Byrne PM. O'Byrne PM. Chest. 2017 Jan;151(1):20-21. doi: 10.1016/j.chest.2016.09.024. Epub 2016 Oct 13. Chest. 2017. PMID: 27746206 No abstract available.
Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK. O'Byrne PM, et al. N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274. N Engl J Med. 2018. PMID: 29768149 Free article. Clinical Trial.
Sounding the alarmins-The role of alarmin cytokines in asthma.
Gauvreau GM, Bergeron C, Boulet LP, Cockcroft DW, Côté A, Davis BE, Leigh R, Myers I, O'Byrne PM, Sehmi R. Gauvreau GM, et al. Among authors: o byrne pm. Allergy. 2023 Feb;78(2):402-417. doi: 10.1111/all.15609. Epub 2022 Dec 14. Allergy. 2023. PMID: 36463491 Free PMC article. Review.
Development of an inhaled anti-TSLP therapy for asthma.
O'Byrne PM, Panettieri RA Jr, Taube C, Brindicci C, Fleming M, Altman P. O'Byrne PM, et al. Pulm Pharmacol Ther. 2023 Feb;78:102184. doi: 10.1016/j.pupt.2022.102184. Epub 2022 Dec 17. Pulm Pharmacol Ther. 2023. PMID: 36535465 Review.
As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.
Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM. Bateman ED, et al. Among authors: o byrne pm. N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275. N Engl J Med. 2018. PMID: 29768147 Free article. Clinical Trial.
Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.
Gauvreau GM, O'Byrne PM, Boulet LP, Wang Y, Cockcroft D, Bigler J, FitzGerald JM, Boedigheimer M, Davis BE, Dias C, Gorski KS, Smith L, Bautista E, Comeau MR, Leigh R, Parnes JR. Gauvreau GM, et al. Among authors: o byrne pm. N Engl J Med. 2014 May 29;370(22):2102-10. doi: 10.1056/NEJMoa1402895. Epub 2014 May 20. N Engl J Med. 2014. PMID: 24846652 Free article. Clinical Trial.
Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet LP, Cockcroft DW, Davis BE, Korn S, Kornmann O, Leigh R, Mayers I, Watz H, Grant SS, Jain M, Cabanski M, Pertel PE, Jones I, Lecot JR, Cao H, O'Byrne PM. Gauvreau GM, et al. Among authors: o byrne pm. Eur Respir J. 2023 Mar 9;61(3):2201193. doi: 10.1183/13993003.01193-2022. Print 2023 Mar. Eur Respir J. 2023. PMID: 36822634 Free PMC article. Clinical Trial.
485 results